超凡国际

Stock code: 002653.SZ
Q

How is the sales performance of Anruikefen Injection, an innovative drug from Guiyang Company? What are the expected sales figures for this year?

A

Our Anruike Fen Injection has just received the "Drug Registration Certificate" issued by the National Medical Products Administration in late May. It is currently in preparation for market launch, and expected to be officially distributed in mid-to-late June. Since injectable products differ from oral formulations, this year’s focus will be on medical insurance negotiations, market preparation, academic promotion, and hospital acceptance, in order to prepare for the full-scale launch of the product next year.

2026-06-22

Q

Could you please inform us whether the company has any research and development efforts in the field of innovative drugs? Which specific products and projects are involved? And what stage have they reached currently? Please provide a detailed explanation. Thank you very much.

A

Our Anruike Fen Injection has just received the "Drug Registration Certificate" issued by the National Medical Products Administration in late May. Currently, preparations are underway for market launch, and it is expected to be officially distributed in mid-to-late June. Since injectable products differ from oral formulations, this year’s focus will be on medical insurance negotiations, market preparation, academic promotion, and hospital acceptance, in order to prepare for the full-scale launch of the product next year.

2026-06-22

Q

Hello, when will your company release the 2025 annual report?

A

Our Anruike Fen Injection has just received the "Drug Registration Certificate" issued by the National Medical Products Administration in late May. It is currently in preparation for market launch, and expected to be officially distributed in mid-to-late June. Since injectable products are different from oral formulations, this year’s focus will be on medical insurance negotiations, market prepping, academic promotion, and hospital acceptance, in order to prepare for the full-scale launch of the product next year.

2026-06-22

Q

How is the sales situation of the innovative drug Anruikefen injection produced by Guiyang Company? What are the expected sales figures for this year?

A

Our Anruike Fen Injection has just received the "Drug Registration Certificate" issued by the National Medical Products Administration in late May. It is currently in preparation for market launch, and expected to be officially distributed in mid-to-late June. Since injectable products are different from oral preparations, this year’s focus will be on medical insurance negotiations, market preparation, academic promotion, and hospital acceptance, in order to prepare for the full-scale launch of the product next year.

2026-06-22

Q

Hello, I am a citizen. I would like to ask if your company has taken any measures during production activities to reduce air pollution. I hope your company can work with us to improve air quality and build a better home.

A

Our Anruike Fen Injection has just received the "Drug Registration Certificate" issued by the National Medical Products Administration in late May. Currently, preparations are underway for market launch, and it is expected to be officially distributed in mid-to-late June. Since injectable products differ from oral formulations, this year’s focus will be on medical insurance negotiations, market preparation, academic promotion, and hospital acceptance, in order to prepare for the full-scale launch of the product next year.

2026-06-22